<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="14321,29987">Glutamate</z:chebi> receptor-mediated neurotoxicity is a major mechanism contributing to <z:e sem="disease" ids="C0752304" disease_type="Disease or Syndrome" abbrv="">hypoxic-ischemic brain injury</z:e> (HIBI) </plain></SENT>
<SENT sid="1" pm="."><plain>Memantine is a safe non-competitive <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor blocker characterized by its low affinity and fast unblocking kinetics </plain></SENT>
<SENT sid="2" pm="."><plain>Topiramate is an AMPA/KA receptor blocker and use-dependent <z:chebi fb="199" ids="26708">sodium</z:chebi> channel blocker with several other neuroprotective actions and little neurotoxicity </plain></SENT>
<SENT sid="3" pm="."><plain>We hypothesized that the coadministration of memantine and topiramate would be highly effective to attenuate HIBI in neonatal rats </plain></SENT>
<SENT sid="4" pm="."><plain>Seven-day-old Sprague-Dawley rat pups were subjected to right common carotid artery ligation and <z:mp ids='MP_0005039'>hypoxia</z:mp> for 2 h, and then were randomly and blindly assigned to one of four groups: vehicle, memantine, topiramate and combination group </plain></SENT>
<SENT sid="5" pm="."><plain>Brain injury was evaluated by gross damage and weight deficit of the right hemisphere at 22d after hypoxic-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (HI) and by neurofunctional assessment (foot-fault test) at 21d post-HI </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> neuronal injury was also evaluated by microscopic damage grading at 72 h post-HI </plain></SENT>
<SENT sid="7" pm="."><plain>Results showed the combination of memantine and topiramate improved both pathological outcome and performance significantly </plain></SENT>
<SENT sid="8" pm="."><plain>The drug-induced apoptotic <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> was assessed by TUNEL staining at 48 h post-HI and the result showed no elevated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:hpo ids='HP_0000001'>all</z:hpo> observed areas </plain></SENT>
<SENT sid="9" pm="."><plain>The result of the experiment indicates the combination therapy is safe and highly effective to reduce brain damage after HIBI </plain></SENT>
</text></document>